在学术健康中心实施个性化医疗。
Implementing Personalized Medicine in the Academic Health Center.
作者信息
Weiss Scott T
机构信息
Partners Center for Personalized Medicine, Partners Health Care, Boston, MA 02115, USA.
出版信息
J Pers Med. 2016 Sep 21;6(3):18. doi: 10.3390/jpm6030018.
Abstract
Recently we at Partners Health Care had a series of articles in the Journal of Personalized Medicine describing how we are going about implementing Personalized Medicine in an academic health care system [1-10].[...].
摘要
最近，我们合作医疗保健公司（Partners Health Care）在《个性化医疗杂志》上发表了一系列文章，描述了我们在学术医疗保健系统中实施个性化医疗的方式[1-10]。[……]
相似文献
1
Implementing Personalized Medicine in the Academic Health Center.在学术健康中心实施个性化医疗。
J Pers Med. 2016 Sep 21;6(3):18. doi: 10.3390/jpm6030018.
2
Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy.个性化医学二十年：个体化药物治疗的过去、现在和未来。
Oncologist. 2019 Jul;24(7):e432-e440. doi: 10.1634/theoncologist.2019-0054. Epub 2019 Apr 2.
3
Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.个体化医学与健康经济学和结果研究的作用：问题、应用、新兴趋势和未来研究。
Value Health. 2013 Sep-Oct;16(6 Suppl):S1-3. doi: 10.1016/j.jval.2013.06.004.
4
Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.肿瘤控制——个性化癌症医学中心：卫生技术评估与结果研究的方法及应用
Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):330-40. doi: 10.1016/j.zefq.2015.06.012. Epub 2015 Jul 28.
5
The Translational Genomics Core at Partners Personalized Medicine: Facilitating the Transition of Research towards Personalized Medicine.合作伙伴个性化医疗的转化基因组学核心：推动研究向个性化医疗的转变。
J Pers Med. 2016 Feb 26;6(1):10. doi: 10.3390/jpm6010010.
6
Strategies for integrating personalized medicine into healthcare practice.将个性化医疗融入医疗实践的策略。
Per Med. 2017 Mar;14(2):141-152. doi: 10.2217/pme-2016-0064. Epub 2017 Jan 19.
7
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.检验医学是否已为个性化医疗时代做好准备？一项针对欧洲医院/医学院校检验医学主任的调查。
Drug Metab Pers Ther. 2015 Jun;30(2):121-8. doi: 10.1515/dmdi-2015-0012.
8
Digital transformation of academic medicine: Breaking barriers, borders, and boredom.医学学术的数字化转型：打破壁垒、疆界与枯燥。
J Pediatr Surg. 2020 Feb;55(2):223-228. doi: 10.1016/j.jpedsurg.2019.10.037. Epub 2019 Nov 9.
9
Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.不断变化的医疗环境中医疗创新的决策：来自责任医疗组织和支付方对个性化医疗及其他技术的见解。
Value Health. 2017 Jan;20(1):40-46. doi: 10.1016/j.jval.2016.09.2402.
10
Commentary: Personalized health planning and the Patient Protection and Affordable Care Act: an opportunity for academic medicine to lead health care reform.述评：个性化健康规划与《患者保护与平价医疗法案》：学术医学引领医疗改革的契机。
Acad Med. 2010 Nov;85(11):1665-8. doi: 10.1097/ACM.0b013e3181f4ab3c.
引用本文的文献
1
Predictive, Personalized, Preventive and Participatory (4P) Medicine Applied to Telemedicine and eHealth in the Literature.文献中应用于远程医疗和电子健康的预测性、个性化、预防性和参与性（4P）医学。
J Med Syst. 2019 Apr 12;43(5):140. doi: 10.1007/s10916-019-1279-4.
2
Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?基于遗传信息生物标志物的戒烟药物治疗：有哪些证据？
Nicotine Tob Res. 2019 Aug 19;21(9):1289-1293. doi: 10.1093/ntr/ntz009.
3
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.戒烟的药物治疗：基于基因信息生物标志物定义的亚组的效果
Cochrane Database Syst Rev. 2017 Sep 8;9(9):CD011823. doi: 10.1002/14651858.CD011823.pub2.
本文引用的文献
1
Infrastructure for Personalized Medicine at Partners HealthCare.合作伙伴医疗保健公司的个性化医疗基础设施。
J Pers Med. 2016 Feb 27;6(1):13. doi: 10.3390/jpm6010013.
2
Bioinformatics Workflow for Clinical Whole Genome Sequencing at Partners HealthCare Personalized Medicine.布莱根妇女医院个性化医疗中心临床全基因组测序的生物信息学工作流程
J Pers Med. 2016 Feb 27;6(1):12. doi: 10.3390/jpm6010012.
3
The Translational Genomics Core at Partners Personalized Medicine: Facilitating the Transition of Research towards Personalized Medicine.合作伙伴个性化医疗的转化基因组学核心：推动研究向个性化医疗的转变。
J Pers Med. 2016 Feb 26;6(1):10. doi: 10.3390/jpm6010010.
4
The Biobank Portal for Partners Personalized Medicine: A Query Tool for Working with Consented Biobank Samples, Genotypes, and Phenotypes Using i2b2.合作伙伴个性化医疗生物样本库门户：一个使用i2b2处理已获同意的生物样本库样本、基因型和表型的查询工具。
J Pers Med. 2016 Feb 26;6(1):11. doi: 10.3390/jpm6010011.
5
The Changing Landscape of Molecular Diagnostic Testing: Implications for Academic Medical Centers.分子诊断检测的不断变化格局：对学术医疗中心的影响。
J Pers Med. 2016 Jan 27;6(1):8. doi: 10.3390/jpm6010008.
6
The Information Technology Infrastructure for the Translational Genomics Core and the Partners Biobank at Partners Personalized Medicine.转化基因组学核心以及合作伙伴个性化医疗生物样本库的信息技术基础设施。
J Pers Med. 2016 Jan 21;6(1):6. doi: 10.3390/jpm6010006.
7
An eMERGE Clinical Center at Partners Personalized Medicine.合作伙伴个性化医疗中心的一个eMERGE临床中心。
J Pers Med. 2016 Jan 20;6(1):5. doi: 10.3390/jpm6010005.
8
Building the Partners HealthCare Biobank at Partners Personalized Medicine: Informed Consent, Return of Research Results, Recruitment Lessons and Operational Considerations.在合作伙伴个性化医疗中心建立合作伙伴医疗生物样本库：知情同意、研究结果反馈、招募经验及操作考量。
J Pers Med. 2016 Jan 14;6(1):2. doi: 10.3390/jpm6010002.
9
Training the Future Leaders in Personalized Medicine.培养个性化医疗领域的未来领导者。
J Pers Med. 2016 Jan 7;6(1):1. doi: 10.3390/jpm6010001.
10
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing.评估基因组测序的成本及成本效益
J Pers Med. 2015 Dec 10;5(4):470-86. doi: 10.3390/jpm5040470.
Zotero 插件